Randomized, Double-Blind, Placebo-Controlled Trial, with Cross-Over, of Posoleucel for the Treatment of Adenovirus Infection in Pediatric and Adult Participants Receiving Standard of Care Following Allogeneic Hematopoietic Cell Transplantation
Clinical Trial Grant
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
Allovir, Inc.
Start Date
October 28, 2022
End Date
October 14, 2024
Administered By
Pediatrics, Transplant and Cellular Therapy
Awarded By
Allovir, Inc.
Start Date
October 28, 2022
End Date
October 14, 2024